Putin Bills Russians $26 Billion For Constant Organ Transplants & New Drug To Survive

Russian citizens are financing a $26 billion scientific initiative aimed at extending the lifespan of their political leadership. The state-funded programme focuses on radical anti-ageing technologies to prolong human life significantly.

Recent disclosures indicate that 73-year-old Vladimir Putin authorised expenditure equivalent to £630 ($800) per family to fund these longevity projects. The financial burden amounts to £154 ($196) per citizen, supporting medical advancements like artificial organ cultivation.

How $26 Billion Funds Pig Organs And New Gene Blockers

Researchers are accelerating clinical projects that explore 3D-printing living tissue and xenotransplantation. This specific procedure involves growing human organs inside genetically compatible mini-pigs for future harvesting.

Medical teams are concurrently developing an experimental treatment designed to halt cellular decline by targeting genetic markers. Denis Sekirinsky, a state-aligned scientist, confirmed researchers aim to create a treatment inhibiting the Receptor for Advanced Glycation Endproducts.

Sekirinsky noted that '[A promising area] is gene therapy of aging.' He further explained that 'The RAGE gene is a receptor whose activation triggers cellular aging, whereas blocking this gene, on the contrary, can prolong cellular youth.'

The technocrat maintains that 'Based on this principle, an ambitious goal has been set — to develop the world's first gene-therapy drug that specifically blocks this receptor.' He added that 'The field relies on advanced genetic technologies and represents one of the most promising avenues in the fight against aging.'

According to Sekirinsky, 'The development is being carried out by the Institute of Biology of Aging and Medicine.' Specialists were recently ordered to submit 'development proposals,' focusing on preventative technologies and bioprinting innovations.

Why Maria Vorontsova Leads The Controversial Medical Research Programme

The health initiative is managed by endocrinologist Maria Vorontsova, 41, alongside Mikhail Kovalchuk, the 79-year-old director of the Kurchatov Institute. Financial backing is reportedly secured through Yuri Kovalchuk, 74, who operates as the state's primary banker.

Every official residence now features highly advanced medical equipment to monitor health metrics. Speaking at an artificial intelligence conference, the Russian leader stated that 'It is probably possible to reach 150.'

He reportedly told President Xi Jinping that 'human organs can be continuously transplanted. The longer you live, the younger you become.' Meanwhile, the ongoing military campaign has resulted in nearly half a million casualties.

Why Experts Believe The 2050 Goal Targets His Son Ivan

The broader national health initiative aims at 'preserving the health,' with goals of preventing 175,000 deaths over six years. However, analysts suggest the primary objective is ensuring the current leadership retains power for decades.

Investigative historian Ilya Davlyatchin proposed that the actual target age for the head of state is 97, which aligns with specific political timelines. Observing this trajectory, Davlyatchin remarked, 'This is the year 2050.'

The historian provided further context regarding the leadership timeline. He added, 'It's simple — then his eldest son Ivan will turn 35 — the age when one can be elected to the [Russian] presidential post.'

Prior to his death last year, Vladimir Khavinson served as the chief adviser for these life-extension projects. The 77-year-old gerontology expert previously described the leader's health as 'perfect,' claiming he was developing protocols to reach 120 years.

Reports indicate that both the head of state and his 42-year-old partner Alina Kabaeva have utilised Khavinson's restorative treatments. These methods were originally developed during classified research conducted within the Soviet Red Army.

The state continues to funnel resources into these procedures despite facing geopolitical setbacks. As scientists race to unlock cellular longevity, the strategy remains fixed on securing a permanent political dynasty.